메뉴 건너뛰기
Clinical Cancer Research
Volumn 14, Issue 1, 2008, Pages 2-3
Another negative chemoprevention trial: What can we learn?
Author keywords

[No Author keywords available]
Indexed keywords

BCG VACCINE; CYCLOOXYGENASE 2 INHIBITOR; EFLORNITHINE; ETRETINATE; FENRETINIDE; PLACEBO; RALOXIFENE; RETINOIC ACID; TAMOXIFEN;
EID: 40749132594     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-2215     Document Type: Editorial
Times cited : (3)
References (8)
  • 1
    • 40749096451 scopus 로고    scopus 로고
    • Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer
    • Sabichi AL, Lerner SP, Atkinson EN, et al. Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer. Clin Cancer Res 2008;14:224-9.
    • (2008) Clin Cancer Res , vol.14 , pp. 224-229
    • Sabichi, A.L.1    Lerner, S.P.2    Atkinson, E.N.3
  • 2
    • 0020404093 scopus 로고
    • Influence of 15 retinoic acid amides on urinary bladder carcinogenesis in the mouse
    • Moon RC, McCormic DL, Becci PJ, et al. Influence of 15 retinoic acid amides on urinary bladder carcinogenesis in the mouse. Carcinogenesis 1982;3:1469-72.
    • (1982) Carcinogenesis , vol.3 , pp. 1469-1472
    • Moon, R.C.1    McCormic, D.L.2    Becci, P.J.3
  • 3
    • 13744259694 scopus 로고    scopus 로고
    • How should we move the field of chemoprevention agent development forward in a productive manner?
    • Meyskens FL, Jr., Szabo E. How should we move the field of chemoprevention agent development forward in a productive manner? Recent Results Cancer Res 2005;166:113-24.
    • (2005) Recent Results Cancer Res , vol.166 , pp. 113-124
    • Meyskens Jr., F.L.1    Szabo, E.2
  • 4
    • 34548104864 scopus 로고    scopus 로고
    • Chemoprevention clinicl trials; it is time to turn success into progress
    • Brown PH. Chemoprevention clinicl trials; it is time to turn success into progress. Cancer Epidemiol Biomarkers Prev 2007;16:1531-2.
    • (2007) Cancer Epidemiol Biomarkers Prev , vol.16 , pp. 1531-1532
    • Brown, P.H.1
  • 5
    • 33645510414 scopus 로고    scopus 로고
    • Reducing the "risk" of chemoprevention: Defining and targeting high risk - 2005 AACR Cancer Research and Prevention Foundation Award Lecture
    • Lippman SM, Lee JJ. Reducing the "risk" of chemoprevention: defining and targeting high risk - 2005 AACR Cancer Research and Prevention Foundation Award Lecture. Cancer Res 2006;66:2893-903.
    • (2006) Cancer Res , vol.66 , pp. 2893-2903
    • Lippman, S.M.1    Lee, J.J.2
  • 6
    • 0027983571 scopus 로고
    • Dose de-escalation chemoprevention trial of α-difluoromethylornithine in patients with colon polyps
    • Meyskens FL, Jr., Emerson SS, Pelot D, et al. Dose de-escalation chemoprevention trial of α-difluoromethylornithine in patients with colon polyps. J Natl Cancer Inst 1994;86:1122-30.
    • (1994) J Natl Cancer Inst , vol.86 , pp. 1122-1130
    • Meyskens Jr., F.L.1    Emerson, S.S.2    Pelot, D.3
  • 7
    • 0042098091 scopus 로고    scopus 로고
    • Effect of α-Difluoromethylornithine on rectal mucosal levels for polyamines in a randomized, double-blinded trial for colon cancer prevention
    • Meyskens FL, Jr., Gerner E, Emerson S, et al. Effect of α-Difluoromethylornithine on rectal mucosal levels for polyamines in a randomized, double-blinded trial for colon cancer prevention. J Natl Cancer Inst 1998;90:1212-8.
    • (1998) J Natl Cancer Inst , vol.90 , pp. 1212-1218
    • Meyskens Jr., F.L.1    Gerner, E.2    Emerson, S.3
  • 8
    • 4944242891 scopus 로고    scopus 로고
    • Polyamines and cancer: Old molecules, new understanding
    • Gerner EW, Meyskens FL, Jr. Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer 2004;4:781-92.
    • (2004) Nat Rev Cancer , vol.4 , pp. 781-792
    • Gerner, E.W.1    Meyskens Jr., F.L.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.